Key Viral Hepatitis Studies Influencing My Practice Following EASL 2022—Audio Recap - a podcast by Clinical Care Options

from 2023-12-12T21:14:12.754949

:: ::

In this episode, Stefan Zeuzem, MD, discusses new viral hepatitis data from EASL 2022, including:

Novel HBV therapeutics, including the REEF-2, B-Clear, and SAVE-1 studies
HBV cure from the Everest Project in China
HDV therapeutics from MYR301 and a study of bulevirtide in patients with cirrhosis and portal hypertension
HCV retreatment in patients with prior direct-acting antiviral therapy failure

Presenter:

Stefan Zeuzem, MD
Professor of Medicine
Chief, Department of Medicine I
JW Goethe University Hospital
Frankfurt, Germany

Follow along with the downloadable slideset at:
https://bit.ly/3yJAruD